David A. Siegel Biocept Inc Transaction History

Two Sigma Advisers, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.75 - $1.2 $4,950 - $7,920	-6,600 Reduced 32.04%	14,000 $13,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $2.27 $10,912 - $28,148	-12,400 Reduced 37.58%	20,600 $19,000
Q1 2022 May 16, 2022	SELL	$1.83 - $3.97 $10,065 - $21,835	-5,500 Reduced 14.29%	33,000 $77,000
Q4 2021 Feb 14, 2022	BUY	$3.43 - $4.22 $132,055 - $162,470	38,500 New	38,500 $139,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.